ARCHIVES

Phase III Regorafenib Trial Meets PFS Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

DCPC Board Defers Decision On Hepatitis Vaccine Study, Rejects PAP Sensitivity Concepts

June 1, 1984

Research Funding In Crisis; Scientists Fear Cancer Program’s Dismantling, AACR Says

January 20, 1995

In Brief: DeVita, FDA Chief Help Kill California Bill Legalizing Laetrile Wit committee Testimony

August 26, 1977

Taxotere Added To Regimen Improves Survival, Study Finds

July 29, 2005

Ralph Steinman Wins Nobel Prize Three Days After His Death

October 14, 2011

Former Senator Cotton Named To NCA

April 11, 1975